Access cutting-edge atherosclerosis cardiovascular disease treatment through this phase 2 clinical trial at a research site in St Louis. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this St Louis location
Preparing your pre-screening questions…
Access atherosclerosis cardiovascular disease specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related atherosclerosis cardiovascular disease treatment provided free
Check if you qualify for this atherosclerosis cardiovascular disease clinical trial in St Louis, MO
No-Cost Study Care
Local to St Louis
Convenient for MO residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This is a multicenter, randomized, double-blind, placebo parallel controlled study to evaluate the preliminary efficacy, safety, and PopPK profile of ABP-745 in patients with ASCVD. Efficacy of ABP-745 in reducing atherosclerotic plaque compared with placebo will be evaluated in participants with ASCVD. The primary efficacy measurement will be assessed at 52W of treatment.
Sponsor: Atom Therapeutics Co., Ltd
Yes, this clinical trial (NCT07303777) has an active research site in St Louis, MO that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for atherosclerosis cardiovascular disease treatment options in St Louis, MO, this clinical trial (NCT07303777) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our St Louis research site is actively enrolling participants for this phase 2 clinical trial. You'll receive care from experienced atherosclerosis cardiovascular disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all atherosclerosis cardiovascular disease clinical trials near you to find additional studies recruiting in your area.
See all heart disease clinical trials recruiting in St Louis — not just this study.
Browse Heart Disease Trials in St Louis →